Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens

NCT01854099 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT01854099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01854099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
Lead sponsor
University of Florida
Phase
Phase 1
Overall status
Withdrawn
Start date
January 31, 2014
Completion date
January 31, 2014
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma